• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Rapid tumor cell proliferation after induction chemotherapy in oropharyngeal cancer.

作者信息

Bourhis J, Wilson G, Wibault P, Janot F, Bosq J, Armand J P, Luboinski B, Malaise E P, Eschwege F

机构信息

Department of Radiotherapy, Institut Gustave Roussy, Villejuif, France.

出版信息

Laryngoscope. 1994 Apr;104(4):468-72. doi: 10.1288/00005537-199404000-00012.

DOI:10.1288/00005537-199404000-00012
PMID:8164487
Abstract

Tumor cell kinetics were studied in vivo in a series of 97 patients with oropharyngeal cancer. The duration of S phase (tS), the labeling index (LI), and the potential doubling time (Tpot) were obtained by flow cytometry measurements of a tumor biopsy obtained after intravenous injection of 200 mg 5-bromodeoxyuridine to the patient. The mean LI was 9.7% (standard deviation [SD], 5.4), the mean tS was 10.1 hours (SD, 3.6), and the mean Tpot was 4.6 days (SD, 3.5). No significant relationship was found between the Tpot or LI and the size of the tumor, nodal status, histological grade, or the site of the primary within the oropharynx. Conversely, aneuploid tumors had longer tS (P < .001), higher LI (P < .001), and shorter Tpot (P < .05) than the diploid tumors. The mean LI and Tpot of the tumors obtained after induction chemotherapy were significantly higher and shorter, respectively, than those measured before any treatment. The data strongly suggest that rapid tumor cell proliferation frequently occurs in oropharyngeal cancer which had responded poorly to chemotherapy.

摘要

相似文献

1
Rapid tumor cell proliferation after induction chemotherapy in oropharyngeal cancer.
Laryngoscope. 1994 Apr;104(4):468-72. doi: 10.1288/00005537-199404000-00012.
2
[Measurement of the kinetics of cell proliferation of cancer of the oropharynx in vivo by the incorporation of bromodeoxyuridine and flow cytometry].[通过溴脱氧尿苷掺入和流式细胞术在体内测量口咽癌细胞增殖动力学]
Bull Cancer. 1991 Nov;78(11):1045-51.
3
[Cell kinetic analysis and treatment planning in epidermoid tumors of the head and neck].[头颈部表皮样肿瘤的细胞动力学分析与治疗规划]
Acta Otorhinolaryngol Ital. 1992 Sep-Oct;12(5):421-33.
4
[The in vivo use of bromodeoxyuridine for the study of cell kinetics in squamous tumors of the neck and head. Implications for the radiotherapist].[溴脱氧尿苷在头颈部鳞状肿瘤细胞动力学研究中的体内应用。对放射治疗师的启示]
Radiol Med. 1991 Jul-Aug;82(1-2):147-52.
5
Overexpression of p53-related proteins predicts rapid growth rate of head and neck cancer.p53相关蛋白的过表达预示着头颈癌的快速生长速度。
Laryngoscope. 2001 Jan;111(1):124-30. doi: 10.1097/00005537-200101000-00022.
6
Proliferation measurements with flow cytometry Tpot in cancer of the uterine cervix: correlation between two laboratories and preliminary clinical results.子宫颈癌中使用流式细胞术检测Tpot进行增殖测量:两个实验室之间的相关性及初步临床结果
Int J Radiat Oncol Biol Phys. 1995 Jul 30;32(5):1319-29. doi: 10.1016/0360-3016(95)00201-9.
7
Potential doubling time and clinical outcome in head and neck squamous cell carcinoma treated with 70 GY in 7 weeks.头颈部鳞状细胞癌接受7周70 Gy治疗后的潜在倍增时间及临床结局
Int J Radiat Oncol Biol Phys. 1996 Jun 1;35(3):471-6. doi: 10.1016/s0360-3016(96)80008-3.
8
Correlation between p53 gene expression and tumor-cell proliferation in oropharyngeal cancer.口咽癌中p53基因表达与肿瘤细胞增殖之间的相关性
Int J Cancer. 1994 May 15;57(4):458-62. doi: 10.1002/ijc.2910570403.
9
[The prognostic role of the parameters of cellular kinetics in head and neck tumors treated solely by radiotherapy].[细胞动力学参数在单纯放疗的头颈部肿瘤中的预后作用]
Radiol Med. 1993 Jul-Aug;86(1-2):135-42.
10
Influence of sampling time on assessment of potential doubling time.
Cytometry. 1994 Jun 1;16(2):144-51. doi: 10.1002/cyto.990160208.

引用本文的文献

1
Is hyperprogressive disease a specific phenomenom of immunotherapy?超进展性疾病是免疫治疗的一种特定现象吗?
Explor Target Antitumor Ther. 2020;1(6):427-433. doi: 10.37349/etat.2020.00027. Epub 2020 Dec 28.
2
Apoptosis as Driver of Therapy-Induced Cancer Repopulation and Acquired Cell-Resistance (CRAC): A Simple In Vitro Model of Phoenix Rising in Prostate Cancer.细胞凋亡作为治疗诱导的肿瘤再增殖和获得性细胞耐药(CRAC)的驱动因素:前列腺癌中凤凰涅槃的简单体外模型。
Int J Mol Sci. 2022 Jan 21;23(3):1152. doi: 10.3390/ijms23031152.
3
Hyperprogression: A novel response pattern under immunotherapy.
超进展:免疫治疗下的一种新型反应模式。
Clin Transl Med. 2020 Sep;10(5):e167. doi: 10.1002/ctm2.167.
4
Adverse effects of chemoradiotherapy on invasion and metastasis of tumor cells.放化疗对肿瘤细胞侵袭和转移的不良反应。
Genes Dis. 2020 Apr 9;7(3):351-358. doi: 10.1016/j.gendis.2020.04.004. eCollection 2020 Sep.
5
Long-Term Survival and Prognostic Factors in Locoregionally Advanced Nasopharyngeal Carcinoma Patients Treated with TPF Induction Chemotherapy followed by Cisplatin-Combined Concurrent Chemoradiotherapy.接受TPF诱导化疗后序贯顺铂同步放化疗的局部区域晚期鼻咽癌患者的长期生存及预后因素
J Cancer. 2019 Jun 24;10(17):3899-3907. doi: 10.7150/jca.31663. eCollection 2019.
6
The Kraken Wakes: induced EMT as a driver of tumour aggression and poor outcome.《海妖觉醒:诱导 EMT 作为肿瘤侵袭和不良预后的驱动因素》。
Clin Exp Metastasis. 2018 Apr;35(4):285-308. doi: 10.1007/s10585-018-9906-x. Epub 2018 Jun 8.
7
Chemotherapy-induced metastasis: mechanisms and translational opportunities.化疗诱导的转移:机制与转化机会。
Clin Exp Metastasis. 2018 Apr;35(4):269-284. doi: 10.1007/s10585-017-9870-x. Epub 2018 Jan 6.
8
Balancing efficacy of and host immune responses to cancer therapy: the yin and yang effects.平衡癌症治疗的疗效和宿主免疫反应:阴阳效应。
Nat Rev Clin Oncol. 2016 Oct;13(10):611-26. doi: 10.1038/nrclinonc.2016.57. Epub 2016 Apr 26.
9
Notch1 regulates angio-supportive bone marrow-derived cells in mice: relevance to chemoresistance.Notch1 调控小鼠血管支持性骨髓来源细胞:与化疗耐药相关。
Blood. 2013 Jul 4;122(1):143-53. doi: 10.1182/blood-2012-11-459347. Epub 2013 May 20.
10
Predictors of locoregional recurrence in T1-2N0 tongue cancer patients.T1-2N0 舌癌患者局部区域复发的预测因素。
Pathol Oncol Res. 2013 Oct;19(4):795-803. doi: 10.1007/s12253-013-9646-9. Epub 2013 May 17.